For the second year running, you turned up for your favourite brands to decide who deserves the ultimate prize... these are ...

So, after a cancer scare in 2015 when Aimee discovered a lump on her breast, the single mom of one decided to undergo genetic ...

There aren’t a lot of dangerous animals where we live, but lately, it seems we are hearing more and more alarming news about ...

May 2026Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor ...

The cognitive effects men with advanced prostate cancer experience during treatment may vary based on the therapy they ...

Oral presentation will highlight favorable outcomes observed among 21 adults and children with KMT2Ar, NPM1m, or NUP98r acute leukemia who ...

Peptides for Hair Growth Good hair days aren’t a myth. When you take a closer look, they’re simply hiding behind the right ...

The TROP2 battle in first-line triple-negative breast cancer has officially kicked off. | A three-way battle among TROP2 ADCs ...

Sir Chris Hoy has expressed hope that a groundbreaking new trial drug could prolong his life. The Team GB hero was given a prognosis of two to four years when he was diagnosed with prostate cancer in ...

The new name underscores that it is not simply a condition relegated to the ovaries but a metabolic and hormonal disorder that can have widespread effects throughout the body. “The term polycystic ...

Flow Pharma, Inc. announced today that it's U.S. Patent application has been allowed for issuance covering a broad-spectrum treatment for Ebola virus infections, utilizing the company's proprietary ...

Sir Chris Hoy has recently shared a number of health updates as he continues his fight against stage four cancer. The Olympic legend's world was turned upside down three years ago when he was ...